Related Experiment Videos
Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae
Abstract:
The role of the cytolytic toxin pneumolysin in the pathogenicity of Streptococcus pneumoniae was investigated. Pneumolysin was purified to homogeneity and used to immunize mice. When these mice were subsequently challenged via the nasal route with virulent S. pneumoniae, they survived significantly longer than control mice. The mean survival times were 5.52 and 2.48 days for immunized and control mice, respectively. This work provides direct evidence for the involvement of pneumolysin in pneumococcal pathogenicity.
Insights
This study investigated the role of pneumolysin, a toxin from Streptococcus pneumoniae, in disease. Mice immunized with pneumolysin showed increased survival against virulent S. pneumoniae infection, demonstrating its role in pathogenicity.
Area of Science:
- Microbiology
- Immunology
- Pathogenesis
Background:
- Streptococcus pneumoniae is a major human pathogen.
- Pneumolysin is a key virulence factor produced by S. pneumoniae.
- Understanding pneumolysin's role is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of pneumolysin in the pathogenicity of Streptococcus pneumoniae.
- To determine if antibodies against pneumolysin can confer protection against S. pneumoniae infection.
Main Methods:
- Pneumolysin was purified to homogeneity.
- Mice were immunized with purified pneumolysin.
- Immunized and control mice were challenged with virulent S. pneumoniae via the nasal route.
Main Results:
- Mice immunized with pneumolysin survived significantly longer than control mice.
- Mean survival time for immunized mice was 5.52 days, compared to 2.48 days for control mice.
Conclusions:
- Pneumolysin plays a significant role in the pathogenicity of Streptococcus pneumoniae.
- Active immunization against pneumolysin can enhance survival during pneumococcal infection.
- These findings provide direct evidence for pneumolysin's contribution to disease severity.